Furanodiene enhances the anti-cancer effects of doxorubicin on ER alpha-negative breast cancer cells in vitro

doi:10.1016/j.ejphar.2015.11.039

CORC > 兰州大学 > 兰州大学 > 药学院 > 期刊论文

	Furanodiene enhances the anti-cancer effects of doxorubicin on ER alpha-negative breast cancer cells in vitro
	Zhong, ZF; Qiang, WA; Wang, CM; Tan, W; Wang, YT; Tan, W (reprint author), Lanzhou Univ, Sch Pharm, 199 West Donggang Rd, Lanzhou 730000, Gansu, Peoples R China.; Wang, YT (reprint author), Univ Macau, Inst Chinese Med Sci, Taipa, Macau, Peoples R China.
刊名	EUROPEAN JOURNAL OF PHARMACOLOGY
	2016-03-05
卷号	774 页码:10-19
关键词	Furanodiene Doxorubicin Combination Breast cancer Apoptosis
ISSN号	0014-2999
DOI	10.1016/j.ejphar.2015.11.039
文献子类	Article
英文摘要	Furanodiene is a natural product isolated from Rhizoma curcumae, and exhibits broad-spectrum anticancer activities in vitro and in vivo. Our previous study proved that furanodiene could increase growth inhibition of steroidal agent in ER alpha-positive breast cancer cells, but whether furanodiene can influence ER status is not clear. In this study, we confirmed that furanodiene down-regulated the ER alpha protein expression level and inhibited E2-induced estrogen response element (ERE)-driven reporter plasmid activity in ER alpha-positive MCF-7 cells. Actually, ERoc-knockdown cells were more sensitive than ER alpha positive cells to furanodiene on the cytotoxicity effect. So the anti-cancer effects of furanodiene and non steroidal agent in breast cancer cells still requires further investigation. Our results showed that furanodiene exposure could enhance growth inhibitory effects of doxorubicin in ERoc-negative MDA-MB-231 cells and ER alpha-low expression 4T1 cells. However, furanodiene did not increase the cytotoxicity of doxorubicin in ER alpha-positive breast cancer cells, non-tumorigenic breast epithelial cells, macrophage cells, hepatocytes cells, pheochromocytoma cells and cardiac myoblasts cells. Furanodiene enhances the anti-cancer effects of doxorubicin in ER alpha-negative breast cancer cells through suppressing cell viability via inducing apoptosis in mitochondria-caspases-dependent and reactive oxygen species-independent manners. These results indicate that furanodiene may be a promising and safety natural agent for cancer adjuvant therapy in the future. (C) 2016 Published by Elsevier B.V.
学科主题	Pharmacology & Pharmacy
出版地	AMSTERDAM
项目编号	Macao Science and Technology Development Fund [077/2011/A3, 048/2013/A2] ; University of Macau [CPG2014-00012-ICMS, UL016/09Y4/CMS/WYT01/ICMS, MYRG208 (Y3-L4)-ICMS11-WYT]
语种	英语
WOS记录号	WOS:000370824100002
内容类型	期刊论文
源URL	[http://ir.lzu.edu.cn/handle/262010/179579]
专题	药学院_期刊论文
通讯作者	Tan, W (reprint author), Lanzhou Univ, Sch Pharm, 199 West Donggang Rd, Lanzhou 730000, Gansu, Peoples R China.; Wang, YT (reprint author), Univ Macau, Inst Chinese Med Sci, Taipa, Macau, Peoples R China.
推荐引用方式 GB/T 7714	Zhong, ZF,Qiang, WA,Wang, CM,et al. Furanodiene enhances the anti-cancer effects of doxorubicin on ER alpha-negative breast cancer cells in vitro[J]. EUROPEAN JOURNAL OF PHARMACOLOGY,2016,774:10-19.
APA	Zhong, ZF.,Qiang, WA.,Wang, CM.,Tan, W.,Wang, YT.,...&Wang, YT .(2016).Furanodiene enhances the anti-cancer effects of doxorubicin on ER alpha-negative breast cancer cells in vitro.EUROPEAN JOURNAL OF PHARMACOLOGY,774,10-19.
MLA	Zhong, ZF,et al."Furanodiene enhances the anti-cancer effects of doxorubicin on ER alpha-negative breast cancer cells in vitro".EUROPEAN JOURNAL OF PHARMACOLOGY 774(2016):10-19.